Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Adverum Biotechnologies, Inc.

Clinical trials sponsored by Adverum Biotechnologies, Inc., explained in plain language.

Trials to join now! 2 Not yet finished but already full! 1

One-shot gene therapy aims to free patients from endless eye injections

Disease control Ongoing

This study is observing the long-term safety and effectiveness of a one-time gene therapy injection for wet age-related macular degeneration (AMD), a leading cause of blindness. It follows 23 people for up to 10 years after they received the therapy in a previous trial. The goal …

Sponsor: Adverum Biotechnologies, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC